期刊文献+

艾拉莫德对博来霉素诱导的肺间质纤维化小鼠模型的影响 被引量:2

Effects of iguratimod on mice model of bleomycin-induced pulmonary fibrosis
原文传递
导出
摘要 目的 研究不同浓度艾拉莫德对博来霉素诱导的肺间质纤维化小鼠模型的影响.方法 将108只C57BL/6小鼠按随机数字表法分成对照组,模型组,艾拉莫德低剂量组、中剂量组、高剂量组及甲泼尼龙组(每组18只).对照组气管内注入0.9%氯化钠注射液0.2 ml,其余5组气管内注入博来霉素(5 mg/kg)建立肺纤维化模型,24 h后分别对对照组、模型组每日用0.2 ml 0.9%氯化钠注射液灌胃,药物组每日分别用不同剂量艾拉莫德(10、30、90 mg/kg)和甲泼尼龙灌胃(10mg/kg).并于造模后第7、14、28天分批处死小鼠,取小鼠肺脏采用苏木精-伊红(HE)染色及Masson染色的方法评估肺泡炎程度及纤维化的程度.统计学方法采用重复测量资料的方差分析,组间比较采用多因素方差分析的LSD检验.结果 ①所有博来霉素诱导组小鼠体质量较对照组均减轻(P〈0.05),而艾拉莫德高剂量组和甲泼尼龙组小鼠在第7、14、28天小鼠体质量较模型组均明显增加(P〈0.05).②与模型组相比,艾拉莫德高剂量组与甲泼尼龙组小鼠第7、14天时肺泡炎评分降低(P〈0.05);第14 d、28天时纤维化评分明显降低(P〈0.05).结论 艾拉莫德高剂量和甲泼尼龙对博来霉素诱导的小鼠肺纤维化模型的肺泡炎和肺纤维化有抑制作用. Objective To explore the effect of different concentrations of iguratimod (IGU) on mouse model of bleomycin-induced pulmonary fibrosis.Methods A total of 108 female C57BL/6 mice were randomly divided into the control group,the model group,the low dose IGU group,the moderate dose IGU group,high dose with group and the methylprednisolone (MP) group (n=18 in each group).The mice in the control group were injected with 0.2 ml normal saline endotracheally,and others were injected with 0.2 ml bleomycin (5 mg/kg) from endotracheally to induce pulmonary fibrosis model.The next day,the mice in both control group and the model group were fed with 0.2 ml normal saline every day;The mice in the IGU groups and methylprednisolone group were fed with 0.2 ml iguratimod liquid the IGU (10,30,90 mg/kg) and 0.2 ml methylprednisolone (10 mg/kg) every dayrespectively.Finally the mice were sacrificed at day 7,day 14,day 28 respectively,and the lung tissue was examined by HE staining and Masson staining to evaluate the degree of alveolitis and fibrosis.Repeated measurement of variance analysis was used to compare the differences for time and group,and multi-factor analysis of variance LSD test was used for the comparison between groups.Results ① The body mass of mice in bleomycin-induced groups were decreased compared to the control group.② The pathological alveolitis scores in the high dose IGU group and methylprednisolone group were significantly decreased compared to those of the model IGU group at day 7 and day 14 (P〈0.05),and the pathological fibrosis scores were decreased dramatically compared with the model group at day 14 and day 28 (P〈0.05).Conclusion High concentration of IGU and methylprednisolone can reduce and inhibit lung inflammation and fibrosis of bleomycin-induced pulmonary fibrosis in mice.
出处 《中华风湿病学杂志》 CSCD 北大核心 2017年第6期370-374,I0001,共6页 Chinese Journal of Rheumatology
关键词 艾拉莫德 博来霉素 肺纤维化 小鼠 近交C57BL Iguratimod Bleomycin Pulmonary fibrosis Mice, inbred C57BL
  • 相关文献

参考文献2

二级参考文献16

  • 1殷红,白金叶,程桂芳.抗炎药物对HEK293细胞NF-κB活化的调节作用[J].药学学报,2005,40(6):513-517. 被引量:5
  • 2蒋叶,吕伟,余书勤,姚琳,绪广林,张锡然.艾拉莫德对脂多糖激活大鼠肺泡巨噬细胞系TNFα产生及NF-κB活性的抑制作用[J].药学学报,2006,41(5):401-405. 被引量:17
  • 3Saag K G,Teng G G,Patkar N M,et al.American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis[J].Arthritis Rheum,2008,59(6):762.
  • 4Ju J H,Kim S I,Lee J H,et al.Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis[J].Arthritis Rheum,2007,56(6):2094.
  • 5Perez-Alvarez R,Perez-de-Lis M,Diaz-Lagares C,et al.Interstitial lung disease induced or exacerbated by TNF-αtargeted therapies:analysis of 122 cases[J].Semin Arthritis Rheum,2011,41(2):256.
  • 6Aletaha D,Neogi T,Silman A J,et al.2010 Rheumatoid arthritis classification criteria:an American College of Rheumatology/European League Against Rheumatism collaborative initiative[J].Arthritis Rheum,2010,62(9):2569.
  • 7Helbich T H,Heinz-Peer G,Eichler I,et al.Cystic fibrosis:CT assessment of lung involvement in children and adults[J].Radiology,1999,213(2):537.
  • 8Kelly C A,Saravanan V,Nisar M,et al.Rheumatoid arthritis-related interstitial lung disease:associations,prognostic factors and physiological and radiological characteristics-a large multicentre UK study[J].Rheumatology(Oxford),2014,53(9):1676.
  • 9Norton S,Koduri G,Nikiphorou E,et al.A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome[J].Rheumatology(Oxford),2013,52(1):99.
  • 10Sheykh Zh V,Krutskevich A O,Drebushevskiy N S,et al.Pulmonary cytotoxicity induced by bleomycin and methotrexate[J].Vestn Rentgenol Radiol,2015,(3):46.

共引文献25

同被引文献35

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部